Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6 - PubMed (original) (raw)

. 1999 Jan:112 ( Pt 1):137-46.

doi: 10.1242/jcs.112.1.137.

Affiliations

• PMID: 9841910
• DOI: 10.1242/jcs.112.1.137

Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6

H Schmitz et al. J Cell Sci. 1999 Jan.

Abstract

Cytokines are supposed to be mediators in diarrhoeal diseases. The aim of this study is to characterize the effect of tumor necrosis factor-alpha (TNFalpha) on epithelial barrier function in the colonic epithelial cell line HT-29/B6. Active ion transport and barrier function were measured as short-circuit current and transepithelial electrical resistance (Rt), respectively. In parallel, freeze-fracture electron microscopy (EM) of tight junctions (TJ) and immunofluorescence microscopy of the zonula occludens protein-1 (ZO-1) were performed. Serosal addition of TNF(alpha) (100 ng/ml) decreased Rt by 81%. This effect was dose-dependent and could be mimicked by antibodies against the p55 form of the TNF receptor. Cytotoxic effects were excluded by a negative lactate dehydrogenase (LDH) assay. Immunofluorescence localization with anti-ZO-1 antibodies revealed no evidence for disruption of the monolayer after TNFalpha treatment. In freeze-fracture EM, TJ complexity was decreased by TNFalpha, as indicated by a decrease in the number of strands from 4.7 to 3.4. The tyrosine kinase blocker genistein and the protein kinase A inhibitor H-8 reduced the effect of TNFalpha. A combination of TNFalpha with interferon-gamma acted synergistically on the epithelial barrier. In conclusion, TNFalpha impairs epithelial barrier function by altering structure and function of the tight junction, which could be of pathogenic relevance in intestinal inflammation.

PubMed Disclaimer

Similar articles

• Supernatants of HIV-infected immune cells affect the barrier function of human HT-29/B6 intestinal epithelial cells.
  Schmitz H, Rokos K, Florian P, Gitter AH, Fromm M, Scholz P, Ullrich R, Zeitz M, Pauli G, Schulzke JD. Schmitz H, et al. AIDS. 2002 May 3;16(7):983-91. doi: 10.1097/00002030-200205030-00004. AIDS. 2002. PMID: 11953464
• GLP-2 enhances barrier formation and attenuates TNFα-induced changes in a Caco-2 cell model of the intestinal barrier.
  Moran GW, O'Neill C, McLaughlin JT. Moran GW, et al. Regul Pept. 2012 Oct 10;178(1-3):95-101. doi: 10.1016/j.regpep.2012.07.002. Epub 2012 Jul 15. Regul Pept. 2012. PMID: 22809889
• Tumor Necrosis Factor Alpha Effects on the Porcine Intestinal Epithelial Barrier Include Enhanced Expression of TNF Receptor 1.
  Droessler L, Cornelius V, Markov AG, Amasheh S. Droessler L, et al. Int J Mol Sci. 2021 Aug 14;22(16):8746. doi: 10.3390/ijms22168746. Int J Mol Sci. 2021. PMID: 34445450 Free PMC article.
• Myrrh exerts barrier-stabilising and -protective effects in HT-29/B6 and Caco-2 intestinal epithelial cells.
  Rosenthal R, Luettig J, Hering NA, Krug SM, Albrecht U, Fromm M, Schulzke JD. Rosenthal R, et al. Int J Colorectal Dis. 2017 May;32(5):623-634. doi: 10.1007/s00384-016-2736-x. Epub 2016 Dec 15. Int J Colorectal Dis. 2017. PMID: 27981377
• (-)-Epicatechin in the prevention of tumor necrosis alpha-induced loss of Caco-2 cell barrier integrity.
  Contreras TC, Ricciardi E, Cremonini E, Oteiza PI. Contreras TC, et al. Arch Biochem Biophys. 2015 May 1;573:84-91. doi: 10.1016/j.abb.2015.01.024. Epub 2015 Mar 17. Arch Biochem Biophys. 2015. PMID: 25795020

Cited by

• Potential mechanisms and targeting strategies of the gut microbiota in antitumor immunity and immunotherapy.
  Yin Q, Ni JJ, Ying JE. Yin Q, et al. Immun Inflamm Dis. 2024 Jul;12(7):e1263. doi: 10.1002/iid3.1263. Immun Inflamm Dis. 2024. PMID: 39031507 Free PMC article. Review.
• Time-dependent effects of tumor necrosis factor α on Ca2+-dependent secretion in murine small intestinal organoids.
  Pauer SM, Buß B, Diener M, Ballout J. Pauer SM, et al. Front Physiol. 2024 Apr 26;15:1382238. doi: 10.3389/fphys.2024.1382238. eCollection 2024. Front Physiol. 2024. PMID: 38737827 Free PMC article.
• Severe intestinal barrier damage in HIV-infected immunological non-responders.
  Guo XY, Guo YT, Wang ZR, Jiao YM, Hu Y, Fan LN, Cheng RQ, Qu MM, Zhang C, Song JW, Xu RN, Fan X, Xu W, Zhang JY, Bai BK, Linghu EQ, Chen YK, Ma P, Wang FS. Guo XY, et al. Heliyon. 2023 Oct 12;9(10):e20790. doi: 10.1016/j.heliyon.2023.e20790. eCollection 2023 Oct. Heliyon. 2023. PMID: 37876458 Free PMC article.
• Establishment of a 96-well transwell system using primary human gut organoids to capture multiple quantitative pathway readouts.
  Wright CW, Li N, Shaffer L, Hill A, Boyer N, Alves SE, Venkataraman S, Biswas K, Lieberman LA, Mohammadi S. Wright CW, et al. Sci Rep. 2023 Sep 29;13(1):16357. doi: 10.1038/s41598-023-43656-z. Sci Rep. 2023. PMID: 37773535 Free PMC article.
• PF-431396 hydrate inhibition of kinase phosphorylation during adherent-invasive Escherichia coli infection inhibits intra-macrophage replication and inflammatory cytokine release.
  Li X, Ormsby MJ, Fallata G, Meikle LM, Walker D, Xu D, Wall DM. Li X, et al. Microbiology (Reading). 2023 Jun;169(6):001337. doi: 10.1099/mic.0.001337. Microbiology (Reading). 2023. PMID: 37311220 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program